{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:35:27Z","timestamp":1768264527902,"version":"3.49.0"},"reference-count":78,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","license":[{"start":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T00:00:00Z","timestamp":1591142400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:sec><jats:title>Abstract<\/jats:title><jats:p>Periodontitis is one of the most prevalent epidemics affecting human health and life recently, and exploration of the pathogenesis and treatment of periodontitis has been valued by scholars. In recent years, sclerostin, a new factor on bone resorption and reconstruction caused by inflammation and mechanical stimulation, has been a research hotspot. This article summarizes the researches on sclerostin in periodontitis development in recent years. Among them, sclerostin has been shown to be a critical negative regulator of bone formation, thereby inhibiting bone remodeling in periodontitis development, and is closely associated with tooth movement. Besides, evidence indicates that the removal of sclerostin seems to reasonably protect the alveolar bone from resorption. Regulation of sclerostin expression is a novel, promising treatment for periodontitis and addresses several complications seen with traditional therapies; accordingly, many drugs with similar mechanisms have emerged. Moreover, the application prospect of sclerostin in periodontal therapy combined with orthodontic treatment is another promising approach. There are also a lot of drugs that regulate sclerostin. Anti-sclerostin antibody (Scl-Ab) is the most direct one that inhibits bone resorption caused by sclerostin. At present, drugs that inhibit the expression of sclerostin have been applied to the treatment of diseases such as multiple myeloma and osteoporosis. Therefore, the application of sclerostin in the oral field is just around the corner, which provides a new therapeutic bone regulation strategy in oral and general health.<\/jats:p><\/jats:sec>","DOI":"10.1097\/cm9.0000000000000764","type":"journal-article","created":{"date-parts":[[2020,6,4]],"date-time":"2020-06-04T01:37:24Z","timestamp":1591234644000},"page":"1456-1461","source":"Crossref","is-referenced-by-count":9,"title":["Sclerostin regulation: a promising therapy for periodontitis by modulating alveolar bone"],"prefix":"10.1097","volume":"133","author":[{"given":"Tian-Jiao","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin-Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Yu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,6,20]]},"reference":[{"key":"R1-20230816","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0140-6736(17)32154-2","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"390","year":"2017","journal-title":"Lancet"},{"key":"R2-20230816","doi-asserted-by":"crossref","first-page":"5525","DOI":"10.3390\/ijms20225525","article-title":"The regulation of bone metabolism and disorders by Wnt signaling","volume":"20","author":"Maeda","year":"2019","journal-title":"Int J Mol Sci"},{"key":"R3-20230816","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.bone.2016.10.010","article-title":"Sclerostin deficiency in humans","volume":"96","author":"van Lierop","year":"2017","journal-title":"Bone"},{"key":"R4-20230816","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1086\/318811","article-title":"Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein","volume":"68","author":"Brunkow","year":"2001","journal-title":"Am J Hum Genet"},{"key":"R5-20230816","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.bone.2007.10.021","article-title":"Bone mineralization density distribution in health and disease","volume":"42","author":"Roschger","year":"2008","journal-title":"Bone"},{"key":"R6-20230816","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s11914-019-00507-z","article-title":"Pro-inflammatory cytokines and osteocytes","volume":"17","author":"Zhou","year":"2019","journal-title":"Curr Osteoporos Rep"},{"key":"R7-20230816","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.bone.2019.02.001","article-title":"Advanced glycation end-product 2 and porphyromonas gingivalis lipopolysaccharide increase sclerostin expression in mouse osteocyte-like cells","volume":"122","author":"Sakamoto","year":"2019","journal-title":"Bone"},{"key":"R8-20230816","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2334\/josnusd.15-0690","article-title":"Effect of sclerostin removal in vivo on experimental periodontitis in mice","volume":"58","author":"Yang","year":"2016","journal-title":"J Oral Sci"},{"key":"R9-20230816","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s11914-019-00509-x","article-title":"The osteocyte as a novel key player in understanding periodontitis through its expression of RANKL and sclerostin: a review","volume":"17","author":"de Vries","year":"2019","journal-title":"Curr Osteoporos Rep"},{"key":"R10-20230816","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1177\/0022034518766874","article-title":"Sclerostin and DKK1 inhibition preserves and augments alveolar bone volume and architecture in rats with alveolar bone loss","volume":"97","author":"Liu","year":"2018","journal-title":"J Dent Res"},{"issue":"(Suppl 1)","key":"R11-20230816","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/ocr.12282","article-title":"Osteocytes and mechanical loading: the Wnt connection","volume":"22","author":"Bullock","year":"2019","journal-title":"Orthod Craniofac Res"},{"key":"R12-20230816","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.bbrc.2019.10.174","article-title":"Mechanotransduction via the Piezo1-Akt pathway underlies Sost suppression in osteocytes","volume":"521","author":"Sasaki","year":"2020","journal-title":"Biochem Biophys Res Commun"},{"key":"R13-20230816","doi-asserted-by":"crossref","first-page":"180262","DOI":"10.1098\/rsob.180262","article-title":"Osteocyte TSC1 promotes sclerostin secretion to restrain osteogenesis in mice","volume":"9","author":"Liu","year":"2019","journal-title":"Open Biol"},{"key":"R14-20230816","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00774-018-0971-7","article-title":"Regulatory mechanisms of sclerostin expression during bone remodeling","volume":"37","author":"Koide","year":"2019","journal-title":"J Bone Miner Metab"},{"key":"R15-20230816","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1365-2842.2010.02068.x","article-title":"The orthodontic-periodontic interrelationship in integrated treatment challenges: a systematic review","volume":"37","author":"Gkantidis","year":"2010","journal-title":"J Oral Rehabil"},{"key":"R16-20230816","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.bone.2019.04.011","article-title":"Sclerostin antibody reduces long bone fractures in the oim\/oim model of osteogenesis imperfecta","volume":"124","author":"Cardinal","year":"2019","journal-title":"Bone"},{"key":"R17-20230816","doi-asserted-by":"crossref","first-page":"e0214520","DOI":"10.1371\/journal.pone.0214520","article-title":"Differential changes in bone strength of two inbred mouse strains following administration of a sclerostin-neutralizing antibody during growth","volume":"14","author":"Mathis","year":"2019","journal-title":"PLoS One"},{"key":"R18-20230816","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.amepre.2018.02.014","article-title":"Effect of smoking on periodontitis: a systematic review and meta-regression","volume":"54","author":"Leite","year":"2018","journal-title":"Am J Prev Med"},{"key":"R19-20230816","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/prd.12235","article-title":"Periodontal complications of hyperglycemia\/diabetes mellitus: Epidemiologic complexity and clinical challenge","volume":"78","author":"Kocher","year":"2018","journal-title":"Periodontol 2000"},{"key":"R20-20230816","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1080\/00325481.2018.1396876","article-title":"Chronic periodontitis, inflammatory cytokines, and interrelationship with other chronic diseases","volume":"130","author":"Cardoso","year":"2018","journal-title":"Postgrad Med"},{"key":"R21-20230816","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/prd.12227","article-title":"Periodontal complications with age","volume":"78","author":"Persson","year":"2018","journal-title":"Periodontol 2000"},{"key":"R22-20230816","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/iej.12612","article-title":"Influence of oestrogen deficiency on the development of apical periodontitis","volume":"50","author":"Brasil","year":"2017","journal-title":"Int Endod J"},{"key":"R23-20230816","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12905-017-0440-9","article-title":"Effect of periodontitis on the development of osteoporosis: results from a nationwide population-based cohort study (2003-2013)","volume":"17","author":"Choi","year":"2017","journal-title":"BMC Womens Health"},{"key":"R24-20230816","doi-asserted-by":"crossref","first-page":"e2348","DOI":"10.1097\/MD.0000000000002348","article-title":"The impact of oral hygiene maintenance on the association between periodontitis and osteoporosis: a nationwide population-based cross sectional study","volume":"95","author":"Huang","year":"2016","journal-title":"Medicine"},{"key":"R25-20230816","doi-asserted-by":"crossref","first-page":"19883","DOI":"10.1074\/jbc.M413274200","article-title":"Sclerostin binds to LRP5\/6 and antagonizes canonical Wnt signaling","volume":"280","author":"Li","year":"2005","journal-title":"J Bio Chem"},{"key":"R26-20230816","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/joim.12368","article-title":"The WNT system: background and its role in bone","volume":"277","author":"Lerner","year":"2015","journal-title":"J Int Med"},{"key":"R27-20230816","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.bone.2016.10.007","article-title":"Role and mechanism of action of sclerostin in bone","volume":"96","author":"Delgado-Calle","year":"2017","journal-title":"Bone"},{"key":"R28-20230816","doi-asserted-by":"crossref","first-page":"e25900","DOI":"10.1371\/journal.pone.0025900","article-title":"Sclerostin stimulates osteocyte support of osteoclast activity by a RANKL-dependent pathway","volume":"6","author":"Wijenayaka","year":"2011","journal-title":"PLoS One"},{"key":"R29-20230816","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/cbin.10696","article-title":"Lipopolysaccharide increases IL-6 secretion via activation of the ERK1\/2 signaling pathway to up-regulate RANKL gene expression in MLO-Y4 cells","volume":"41","author":"Yu","year":"2017","journal-title":"Cell Biol Int"},{"key":"R30-20230816","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/s00223-016-0144-4","article-title":"Osterix and RUNX2 are transcriptional regulators of sclerostin in human bone","volume":"99","author":"Perez-Campo","year":"2016","journal-title":"Calcified Tissue Int"},{"key":"R31-20230816","doi-asserted-by":"crossref","first-page":"15005","DOI":"10.1038\/boneres.2015.5","article-title":"TGF-beta\/BMP signaling and other molecular events: regulation of osteoblastogenesis and bone formation","volume":"3","author":"Rahman","year":"2015","journal-title":"Bone Res"},{"key":"R32-20230816","doi-asserted-by":"crossref","first-page":"615486","DOI":"10.1155\/2015\/615486","article-title":"Mechanisms of bone resorption in periodontitis","volume":"2015","author":"Hienz","year":"2015","journal-title":"J Immunol Res"},{"key":"R33-20230816","first-page":"1083","article-title":"Osteogenic response of mesenchymal stem cells to continuous mechanical strain is dependent on ERK1\/2-Runx2 signaling","volume":"29","author":"Zhang","year":"2012","journal-title":"Int J Mol Med"},{"key":"R34-20230816","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/978-1-4939-6424-6_16","article-title":"Quantifying tensile force and ERK phosphorylation on actin stress fibers","volume":"1487","author":"Hirata","year":"2017","journal-title":"Methods Mol Biol"},{"key":"R35-20230816","doi-asserted-by":"crossref","first-page":"4673","DOI":"10.1038\/s41467-018-07150-9","article-title":"Integrating chemical and mechanical signals through dynamic coupling between cellular protrusions and pulsed ERK activation","volume":"9","author":"Yang","year":"2018","journal-title":"Nat Commun"},{"key":"R36-20230816","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.bone.2004.10.016","article-title":"Extracellular nucleotides activate Runx2 in the osteoblast-like HOBIT cell line: a possible molecular link between mechanical stress and osteoblasts\u2019 response","volume":"36","author":"Costessi","year":"2005","journal-title":"Bone"},{"key":"R37-20230816","doi-asserted-by":"crossref","first-page":"e0167312","DOI":"10.1371\/journal.pone.0167312","article-title":"Sclerostin promotes bone remodeling in the process of tooth movement","volume":"12","author":"Shu","year":"2017","journal-title":"PLoS One"},{"key":"R38-20230816","doi-asserted-by":"crossref","first-page":"5866","DOI":"10.1074\/jbc.M705092200","article-title":"Mechanical stimulation of bone in vivo reduces osteocyte expression of Sost\/sclerostin","volume":"283","author":"Robling","year":"2008","journal-title":"J Biol Chem"},{"key":"R39-20230816","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1007\/s00198-011-1656-4","article-title":"Mechanical loading-related changes in osteocyte sclerostin expression in mice are more closely associated with the subsequent osteogenic response than the peak strains engendered","volume":"23","author":"Moustafa","year":"2012","journal-title":"Osteoporos Int"},{"issue":"(Suppl 1)","key":"R40-20230816","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1007\/s40520-013-0101-2","article-title":"Mechanobiology of bone","volume":"25","author":"Iolascon","year":"2013","journal-title":"Aging Clin Exp Res"},{"issue":"(Suppl 16)","key":"R41-20230816","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1111\/jcpe.12382","article-title":"Primary and secondary prevention of periodontal and peri-implant diseases: Introduction to, and objectives of the 11th European Workshop on Periodontology consensus conference","volume":"42","author":"Tonetti","year":"2015","journal-title":"J Clin Periodontol"},{"key":"R42-20230816","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.3760\/cma.j.issn.0366-6999.20130104","article-title":"Serum sclerostin levels associated with lumbar spine bone mineral density and bone turnover markers in patients with postmenopausal osteoporosis","volume":"126","author":"Xu","year":"2013","journal-title":"Chin Med J"},{"key":"R43-20230816","doi-asserted-by":"crossref","first-page":"571","DOI":"10.2174\/1566524023362104","article-title":"Bisphosphonate mechanism of action","volume":"2","author":"Rodan","year":"2002","journal-title":"Curr Mol Med"},{"key":"R44-20230816","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1111\/ijcp.12022","article-title":"Denosumab: mechanism of action and clinical outcomes","volume":"66","author":"Hanley","year":"2012","journal-title":"Int J Clin Pract"},{"key":"R45-20230816","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jocd.2016.09.005","article-title":"Case-based review of osteonecrosis of the jaw (ONJ) and application of the international recommendations for management from the international task force on ONJ","volume":"20","author":"Khan","year":"2017","journal-title":"J Clin Densitom"},{"key":"R46-20230816","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1177\/0192623317737066","article-title":"Antiresorptives: safety concerns-clinical perspective","volume":"45","author":"Brown","year":"2017","journal-title":"Toxicol Pathol"},{"key":"R47-20230816","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1359\/jbmr.2001.16.3.448","article-title":"Parathyroid hormone\/parathyroid hormone-related peptide type 1 receptor in human bone","volume":"16","author":"Langub","year":"2001","journal-title":"J Bone Minerl Res"},{"key":"R48-20230816","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.archoralbio.2017.06.033","article-title":"Intermittent administration of parathyroid hormone ameliorated alveolar bone loss in experimental periodontitis in streptozotocin-induced diabetic rats","volume":"83","author":"Chen","year":"2017","journal-title":"Arch Oral Biol"},{"key":"R49-20230816","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.archoralbio.2017.06.013","article-title":"Parathyroid hormone-related peptide (1-34) reduces alveolar bone loss in type 1 diabetic rats","volume":"83","author":"Zhang","year":"2017","journal-title":"Arch Oral Biol"},{"key":"R50-20230816","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/jcpe.12854","article-title":"Antagonists of Wnt\/beta-catenin signalling in the periodontitis associated with type 2 diabetes and smoking","volume":"45","author":"Miranda","year":"2018","journal-title":"J Clin Periodontol"},{"key":"R51-20230816","doi-asserted-by":"crossref","first-page":"e0189702","DOI":"10.1371\/journal.pone.0189702","article-title":"Tumor necrosis factor-alpha antagonist diminishes osteocytic RANKL and sclerostin expression in diabetes rats with periodontitis","volume":"12","author":"Kim","year":"2017","journal-title":"PLoS One"},{"key":"R52-20230816","doi-asserted-by":"crossref","first-page":"e0184904","DOI":"10.1371\/journal.pone.0184904","article-title":"Treatment of OPG-deficient mice with WP9QY, a RANKL-binding peptide, recovers alveolar bone loss by suppressing osteoclastogenesis and enhancing osteoblastogenesis","volume":"12","author":"Ozaki","year":"2017","journal-title":"PLoS One"},{"key":"R53-20230816","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/nyas.13433","article-title":"Therapeutic applications of resveratrol and its derivatives on periodontitis","volume":"1403","author":"Chin","year":"2017","journal-title":"Ann N Y Acad Sci"},{"key":"R54-20230816","doi-asserted-by":"crossref","first-page":"953","DOI":"10.3390\/nu11050953","article-title":"Can resveratrol treatment control the progression of induced periodontal disease? A systematic review and meta-analysis of preclinical studies","volume":"11","author":"Andrade","year":"2019","journal-title":"Nutrients"},{"key":"R55-20230816","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/jcb.27401","article-title":"Structural insights of resveratrol with its binding partners in the toll-like receptor 4 pathway","volume":"120","author":"Saqib","year":"2019","journal-title":"J Cell Biochem"},{"key":"R56-20230816","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.freeradbiomed.2014.07.034","article-title":"Resveratrol improves oxidative stress and prevents the progression of periodontitis via the activation of the Sirt1\/AMPK and the Nrf2\/antioxidant defense pathways in a rat periodontitis model","volume":"75","author":"Tamaki","year":"2014","journal-title":"Free Radic Biol Med"},{"key":"R57-20230816","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1902\/jop.2017.170025","article-title":"Resveratrol inhibits periodontitis-related bone loss in rats subjected to cigarette smoke inhalation","volume":"88","author":"Ribeiro","year":"2017","journal-title":"J Periodontol"},{"key":"R58-20230816","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1002\/jbmr.1984","article-title":"Sclerostin antibody stimulates bone regeneration after experimental periodontitis","volume":"28","author":"Taut","year":"2013","journal-title":"J Bone Miner Res"},{"key":"R59-20230816","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.bone.2015.04.002","article-title":"Sclerostin antibody treatment causes greater alveolar crest height and bone mass in an ovariectomized rat model of localized periodontitis","volume":"76","author":"Chen","year":"2015","journal-title":"Bone"},{"key":"R60-20230816","doi-asserted-by":"crossref","first-page":"10890","DOI":"10.1074\/jbc.M807994200","article-title":"Characterization of the structural features and interactions of sclerostin: molecular insight into a key regulator of Wnt-mediated bone formation","volume":"284","author":"Veverka","year":"2009","journal-title":"J Biol Chem"},{"key":"R61-20230816","doi-asserted-by":"crossref","first-page":"e62295","DOI":"10.1371\/journal.pone.0062295","article-title":"Anti-sclerostin antibody inhibits internalization of sclerostin and sclerostin-mediated antagonism of Wnt\/LRP6 signaling","volume":"8","author":"van Dinther","year":"2013","journal-title":"PLoS One"},{"key":"R62-20230816","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1002\/jbmr.14","article-title":"Two doses of sclerostin antibody in cynomolgus monkeys increases bone formation, bone mineral density, and bone strength","volume":"25","author":"Ominsky","year":"2010","journal-title":"J Bone Miner Res"},{"key":"R63-20230816","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1002\/hed.25128","article-title":"Treatment with anti-Sclerostin antibody to stimulate mandibular bone formation","volume":"40","author":"Tamplen","year":"2018","journal-title":"Head Neck"},{"key":"R64-20230816","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/jor.23726","article-title":"Sclerostin antibody enhances bone formation in a rat model of distraction osteogenesis","volume":"36","author":"McDonald","year":"2018","journal-title":"J Orthop Res"},{"key":"R65-20230816","doi-asserted-by":"crossref","first-page":"R33","DOI":"10.1530\/EJE-17-0920","article-title":"Management of endocrine disease: novel anabolic treatments for osteoporosis","volume":"178","author":"Canalis","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"R66-20230816","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ejphar.2018.02.028","article-title":"Targeted inhibition of sclerostin for post-menopausal osteoporosis therapy: a critical assessment of the mechanism of action","volume":"826","author":"Bhattacharyya","year":"2018","journal-title":"Eur J Pharmacol"},{"key":"R67-20230816","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1182\/blood-2017-03-773341","article-title":"Inhibiting the osteocyte-specific protein sclerostin increases bone mass and fracture resistance in multiple myeloma","volume":"129","author":"McDonald","year":"2017","journal-title":"Blood"},{"key":"R68-20230816","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.3389\/fimmu.2018.02467","article-title":"Role of osteocytes in myeloma bone disease: anti-sclerostin antibody as new therapeutic strategy","volume":"9","author":"Toscani","year":"2018","journal-title":"Front Immunol"},{"key":"R69-20230816","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1089\/ten.tea.2018.0013","article-title":"Sclerostin-neutralizing antibody enhances bone regeneration around oral implants","volume":"24","author":"Yu","year":"2018","journal-title":"Tissue Eng Part A"},{"key":"R70-20230816","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2106\/JBJS.N.00654","article-title":"Sclerostin antibody treatment improves implant fixation in a model of severe osteoporosis","volume":"97","author":"Virdi","year":"2015","journal-title":"J Bone Joint Surg Am"},{"key":"R71-20230816","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.ajodo.2017.08.018","article-title":"Orthodontic treatment in patients with aggressive periodontitis","volume":"153","author":"Carvalho","year":"2018","journal-title":"Am J Orthod Dentofacial Orthop"},{"key":"R72-20230816","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/jcpe.12835","article-title":"Orthodontic treatment simultaneous to or after periodontal cause-related treatment in periodontitis susceptible patients. Part I: a randomized clinical trial","volume":"45","author":"Zasciurinskiene","year":"2018","journal-title":"J Clin Periodontol"},{"key":"R73-20230816","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.ajodo.2017.01.028","article-title":"Efficacy of combined orthodontic-periodontic treatment for patients with periodontitis and its effect on inflammatory cytokines: a comparative study","volume":"152","author":"Zhang","year":"2017","journal-title":"Am J Orthod Dentofacial Orthop"},{"key":"R74-20230816","first-page":"450","article-title":"Severe periodontitis and orthodontics: how far should we go?","volume":"16","author":"Kruk","year":"2018","journal-title":"Int Orthod"},{"key":"R75-20230816","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3389\/fendo.2019.00285","article-title":"The role of osteocytes in inflammatory bone loss","volume":"10","author":"Metzger","year":"2019","journal-title":"Front Endocrinol"},{"key":"R76-20230816","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.bone.2007.09.047","article-title":"Osteocytes as mechanosensors in the inhibition of bone resorption due to mechanical loading","volume":"42","author":"You","year":"2008","journal-title":"Bone"},{"key":"R77-20230816","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-1119(03)00841-2","article-title":"Tumor necrosis factor-alpha: molecular and cellular mechanisms in skeletal pathology","volume":"321","author":"Nanes","year":"2003","journal-title":"Gene"},{"key":"R78-20230816","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.cytogfr.2004.06.004","article-title":"The molecular triad OPG\/RANK\/RANKL: involvement in the orchestration of pathophysiological bone remodeling","volume":"15","author":"Theoleyre","year":"2004","journal-title":"Cytokine Growth Factor Rev"}],"container-title":["Chinese Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000000764","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T22:30:00Z","timestamp":1722983400000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000000764"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,3]]},"references-count":78,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/cm9.0000000000000764","relation":{},"ISSN":["0366-6999","2542-5641"],"issn-type":[{"value":"0366-6999","type":"print"},{"value":"2542-5641","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,3]]}}}